Oscar Health Stock Is a Screaming Buy Right Now

A Feb. 10, 2026 video reviews Oscar Health's (NYSE: OSCR) recent earnings report and conference call but the article contains no revenue, earnings, guidance or other quantitative financial metrics. Motley Fool's Stock Advisor did not include Oscar Health among its top-10 stock picks, and the presenter discloses a personal position in OSCR and affiliate compensation, a conflict investors should factor into any investment decision.

Analysis

Market structure: Oscar (OSCR) sits in a bifurcated market where scale incumbents (e.g., UNH, HUM) benefit from underwriting leverage and provider contracting power while smaller, tech-driven players compete on enrollee experience and distribution. A weak print or guide for membership/margins will directly benefit large-cap payers (market-share consolidation) and hurt smaller insurers and reinsurers exposed to individual/MA segments; expect 5–25% idiosyncratic moves depending on guidance clarity. Cross-asset: a marked deterioration in OSCR profitability would raise credit spreads for small-cap insurers and push equity-volatility in the group higher; limited FX or commodity impact but some spill to high-yield insurance paper and options skew for the sector.

Risk assessment: Tail risks include adverse CMS/ACA policy changes (risk-adjustment reductions or benchmark cuts), a provider contracting breakdown creating c.10–20% hit to medical-loss ratios, or an investor liquidity squeeze prompting quick deleveraging. Time horizons: immediate (days) — volatility around earnings and guidance; short-term (weeks–months) — enrollment windows and CMS rate notices; long-term (quarters–years) — path to adjusted EBITDA profitability and unit economics. Hidden dependencies: membership mix (ACA vs MA) and reinsurance pricing drive margins more than headline revenue growth; provider network leverage can flip economics quickly. Catalysts to watch: next 60–90 days of enrollment data, CMS draft rates, and any updates to risk-adjustment methodology.

Trade implications: Direct plays favor small, tactical positions — pair trades that long scaled incumbents (UNH) and short OSCR capture consolidation risk; options trades (3–6 month 25–35 delta puts on OSCR) are cheap asymmetric hedges if IV>35%. Sector rotation: reduce generic small-cap insurer exposure by 1–3% and reallocate to 2–4% positions in large-cap diversified payers and managed-care names. Entry/exit: use earnings and CMS notices in the next 30–90 days as primary execution windows and enforce 10–15% hard stops on directional positions.

Contrarian angles: The market likely underestimates successful unit-economics inflection if Oscar nails MA mix and tightens provider rates — a miss on current quarters could be overdone and create a buying opportunity 20–40% below recent levels. Historical parallels: smaller disruptors (e.g., prior public insurer roll-ups) saw outsized rebounds when membership trends stabilized and loss ratios improved; conversely, regulatory shocks caused permanent value impairment. Unintended consequence: aggressive shorting could pressure management into margin-accretive but growth-stunting pricing or M&A that revalues the equity — size positions accordingly.

Key Decisions for Investors

• If OSCR issues weaker-than-expected guidance or misses key margin metrics, purchase 3-month 25–35 delta puts sized to 0.8–1.2% of portfolio value; target a 25–40% nominal decline within 60–90 days and cut position if OSCR rallies >15% from entry.
• Implement a pair trade: establish a long UnitedHealth (UNH) position sized 2–3% of portfolio and a short OSCR sized 1–1.5% to express scale/contracting tailwinds vs small-cap execution risk; reprice after next earnings/CMS notices (review in 30–60 days).
• If taking a constructive longer-term stance on OSCR after a post-earnings sell-off (>25% drop), initiate a small 1.5–2% long position funded by selling 1–2x three-month covered calls 15% OTM to reduce cost basis; unwind or add if medical-loss ratio improves by >200bps quarter-over-quarter.
• Monitor specific catalysts over the next 30–90 days: CMS draft rate notices, ACA risk-adjustment guidance, and month-by-month enrollment trends; add up to 1–2% long exposure if CMS actions are favorable or enrollment growth exceeds +5% YoY.